Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria.|Theodor Escherich Laboratory for Microbiome Research, Medical University of Graz, Austria.
Walter
W
Spindelboeck
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Eduard
E
Schulz
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Barbara
B
Uhl
Institute of Pathology, Medical University of Graz, Austria.
Karl
K
Kashofer
Institute of Pathology, Medical University of Graz, Austria.
Ariane
A
Aigelsreiter
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Wilma
W
Zinke-Cerwenka
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Adnan
A
Mulabecirovic
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria.|Theodor Escherich Laboratory for Microbiome Research, Medical University of Graz, Austria.
Patrizia K
PK
Kump
Theodor Escherich Laboratory for Microbiome Research, Medical University of Graz, Austria.|Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.|Institute of Pathology, Medical University of Graz, Austria.
Bettina
B
Halwachs
Theodor Escherich Laboratory for Microbiome Research, Medical University of Graz, Austria.|Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.|Institute of Pathology, Medical University of Graz, Austria.
Gregor
G
Gorkiewicz
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Heinz
H
Sill
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria.
Hildegard
H
Greinix
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Austria christoph.hoegenauer@medunigraz.at peter.neumeister@medunigraz.at.|Theodor Escherich Laboratory for Microbiome Research, Medical University of Graz, Austria.
Christoph
C
Högenauer
Division of Hematology, Department of Internal Medicine, Medical University of Graz, Austria christoph.hoegenauer@medunigraz.at peter.neumeister@medunigraz.at.
Peter
P
Neumeister
D003131:Combined Modality Therapy; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D000069467:Fecal Microbiota Transplantation; D005243:Feces / Q000382:microbiology*; D005260:Female; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome